Search research articles
Contact Us
Filters
Showing results (391-400 of 494) with videos related to
Page
of 50
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 9, 2021
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial
Amita Patnaik, Glen J Weiss, Drew W Rasco, et al.
Vaccine
|
June 17, 2008
A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
Jennifer A McEachern, John Bingham, Gary Crameri, et al.
Journal of Medicinal Chemistry
|
May 9, 2013
A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice
Rong Sheng, Haiying Sun, Liu Liu, et al.
Molecular Cancer Therapeutics
|
February 2, 2011
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases
Jie Yang, Donna McEachern, Wenyan Li, et al.
Journal of Inherited Metabolic Disease
|
March 26, 2010
Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
John Marshall, Kerry Anne McEachern, Wei-Lien Chuang, et al.
Journal of Virological Methods
|
May 13, 2009
A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein
Yoshihiro Kaku, Akira Noguchi, Glenn A Marsh, et al.
Journal of Medicinal Chemistry
|
March 23, 2026
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader
Dimin Wu, Haibin Zhou, Longchuan Bai, et al.
Plos One
|
December 3, 2010
Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease
John Marshall, Karen M Ashe, Dinesh Bangari, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 11, 2023
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
Linda A Chamberlin, Sha-Sha Yang, Erin P McEachern, et al.
The Journal of Infectious Diseases
|
February 15, 2008
Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody
Zhongyu Zhu, Katharine N Bossart, Kimberly A Bishop, et al.
Page
of 50
Search research articles
Search
Showing results (391-400 of 494) with videos related to
Sort By:
Page
of 50
Cancer Chemotherapy and Pharmacology
|
November 9, 2021
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial
Amita Patnaik, Glen J Weiss, Drew W Rasco, et al.
Vaccine
|
June 17, 2008
A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
Jennifer A McEachern, John Bingham, Gary Crameri, et al.
Journal of Medicinal Chemistry
|
May 9, 2013
A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice
Rong Sheng, Haiying Sun, Liu Liu, et al.
Molecular Cancer Therapeutics
|
February 2, 2011
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases
Jie Yang, Donna McEachern, Wenyan Li, et al.
Journal of Inherited Metabolic Disease
|
March 26, 2010
Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
John Marshall, Kerry Anne McEachern, Wei-Lien Chuang, et al.
Journal of Virological Methods
|
May 13, 2009
A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein
Yoshihiro Kaku, Akira Noguchi, Glenn A Marsh, et al.
Journal of Medicinal Chemistry
|
March 23, 2026
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader
Dimin Wu, Haibin Zhou, Longchuan Bai, et al.
Plos One
|
December 3, 2010
Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease
John Marshall, Karen M Ashe, Dinesh Bangari, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 11, 2023
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
Linda A Chamberlin, Sha-Sha Yang, Erin P McEachern, et al.
The Journal of Infectious Diseases
|
February 15, 2008
Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody
Zhongyu Zhu, Katharine N Bossart, Kimberly A Bishop, et al.
Page
of 50